Bone Marrow TransplantationTransplantation, HomologousBone MarrowBone Marrow CellsGraft vs Host DiseaseWhole-Body IrradiationHematopoietic Stem Cell TransplantationBone and BonesTransplantation ChimeraTransplantation ConditioningGraft SurvivalLeukemiaAnemia, AplasticHematopoietic Stem CellsRadiation ChimeraTissue DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Tumor EffectBusulfanHematologic NeoplasmsLeukocyte TransfusionHistocompatibility TestingMice, Inbred C57BLTransplantation, AutologousHistocompatibilityGraft vs Host ReactionLymphocyte DepletionGraft vs Leukemia EffectRecurrenceLeukemia, Myeloid, AcuteT-LymphocytesTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisChimeraBone Marrow DiseasesRemission InductionMice, Inbred BALB CBone RemodelingAcute DiseaseBone Marrow PurgingImmunosuppressionBone Marrow ExaminationImmunosuppressive AgentsCyclophosphamideTime FactorsMyelodysplastic SyndromesLeukemia, MyeloidLymphocyte TransfusionGraft RejectionBone Marrow NeoplasmsSpleenAntigens, CD34Transplantation ImmunologyTreatment OutcomeFlow CytometryLymphocyte Culture Test, MixedSkin TransplantationIsoantigensCytomegalovirus InfectionsColony-Forming Units AssayNuclear FamilyCombined Modality TherapyBone DensityHepatic Veno-Occlusive DiseaseGranulocyte Colony-Stimulating FactorCell DifferentiationCyclosporineStem Cell TransplantationCells, CulturedHematologic DiseasesHLA AntigensSurvival AnalysisGraft Enhancement, ImmunologicMice, SCIDHost vs Graft ReactionChimerismRetrospective StudiesLymphocyte ActivationMice, Inbred StrainsImmunophenotypingBone ResorptionSevere Combined ImmunodeficiencyMice, Inbred C3HCell SeparationMultiple MyelomaAntigens, CDHematopoietic Stem Cell MobilizationLeukocyte CountImmune ToleranceActuarial AnalysisCytotoxicity, ImmunologicThymus GlandSurvival RatePeripheral Blood Stem Cell TransplantationFatal OutcomeTransplantation ToleranceLymphocytesAntibodies, MonoclonalPancytopenia